Literature DB >> 28968732

Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.

Takehito Ishido1, Nobuyuki Horita2, Masaki Takeuchi1, Tatsukata Kawagoe1, Etsuko Shibuya1, Takahiro Yamane1, Takahiko Hayashi1, Akira Meguro1, Mizuho Ishido1, Kaoru Minegishi3, Ryusuke Yoshimi3, Yohei Kirino3, Shingo Kato4, Jun Arimoto4, Yoshiaki Ishigatsubo5, Mitsuhiro Takeno6, Michiko Kurosawa7, Takeshi Kaneko2, Nobuhisa Mizuki1.   

Abstract

Objective: This report aimed to scrutinize the prevalence of Behçet's disease (BD)-related clinical manifestations based on age- and sex-specific subgroups using a Japanese nationwide registration database.
Methods: The database of newly registered BD was obtained from the Japanese Ministry of Health, Labour and Welfare. Patients who met the International Criteria for Behçet's Disease were selected and analysed.
Results: Among 6627 International Criteria for Behçet's Disease cases, 2651 (40.0%) were men and 3976 (60.0%) were women with a median age of 39 years (interquartile range: 31-50 years). Ocular lesion was more common in male [odds ratio (male: female) 2.64 (95% CI: 2.35, 2.95, P < 0.001)] and genital ulceration was more common in female (odds ratio = 0.29, 95% CI: 0.25, 0.32, P < 0.001). Ocular lesion (P < 0.001), arthritis (P < 0.001) and vascular lesions (P < 0.001) were more frequently observed in elderly registered patients. Contrarily, genital ulceration (P < 0.001), epididymitis of males (P = 0.023) and oral ulceration (P = 0.003) were more common in younger patients. Simultaneous assessment of sex and age revealed that male predominance of ocular involvement was found in the young adult generation, but not in patients over 70 year of age. A female predominance of genital ulcer was prominently observed in patients 20-59 year of age; however, the sex difference was not found in patients over 60 years of age. Sensitivity analysis using International Study Group criteria replicated the results.
Conclusion: We showed that clinical phenotype in early phase of BD was different depending on onset age and sex.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  Behçet’s syndrome; diagnosis; epidemiology; surveys and questionnaires

Mesh:

Substances:

Year:  2017        PMID: 28968732     DOI: 10.1093/rheumatology/kex285

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  Geographical variations in ocular and extra-ocular manifestations in Behçet's disease.

Authors:  Farhad Shahram; Marthe T Mæhlen; Massoomeh Akhlaghi; Fereydoun Davatchi; Yaping Joyce Liao; Cornelia M Weyand
Journal:  Eur J Rheumatol       Date:  2019-07-19

Review 2.  Diagnostic/classification criteria in pediatric Behçet's disease.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-11-14       Impact factor: 2.631

3.  Purtscher-like retinopathy with macular ischemia as the initial presentation of Behcet's disease.

Authors:  Min Ho Shin; Woong Sun Yoo; Ji Sung Jung; In Young Chung
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

4.  Cutaneous and Extracutaneous Manifestations of Behçet's Disease Linked to Its Disease Activity and Prognosis.

Authors:  Preeyachat Limtong; Kumutnart Chanprapaph; Vasanop Vachiramon; Pintip Ngamjanyaporn
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-08-25

5.  Epidemiology and treatment of Behçet's disease in the USA: insights from the Rheumatology Informatics System for Effectiveness (RISE) Registry with a comparison with other published cohorts from endemic regions.

Authors:  Nevin Hammam; Jing Li; Michael Evans; Julia L Kay; Zara Izadi; Christine Anastasiou; Milena A Gianfrancesco; Jinoos Yazdany; Gabriela Schmajuk
Journal:  Arthritis Res Ther       Date:  2021-08-30       Impact factor: 5.606

6.  Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet's disease in the Shanghai Adamantiades-Behçet's disease database: a prospective cohort study.

Authors:  Liang Zhang; Yun Tian; Jing-Fen Ye; Chen-Hong Lin; Jian-Long Guan
Journal:  Orphanet J Rare Dis       Date:  2019-11-28       Impact factor: 4.123

7.  Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan.

Authors:  Yutaro Soejima; Yohei Kirino; Mitsuhiro Takeno; Michiko Kurosawa; Masaki Takeuchi; Ryusuke Yoshimi; Yumiko Sugiyama; Shigeru Ohno; Yukiko Asami; Akiko Sekiguchi; Toshihisa Igarashi; Shohei Nagaoka; Yoshiaki Ishigatsubo; Hideaki Nakajima; Nobuhisa Mizuki
Journal:  Arthritis Res Ther       Date:  2021-02-01       Impact factor: 5.156

8.  Clinical characteristics and risk factors of intestinal involvement in Behçet's syndrome patients: a cross-sectional study from a single center.

Authors:  Cheng-Cheng Hou; Jing-Fen Ye; Hai-Fen Ma; Jian-Long Guan
Journal:  Orphanet J Rare Dis       Date:  2021-03-17       Impact factor: 4.123

9.  Cluster analysis of phenotypes of patients with Behçet's syndrome: a large cohort study from a referral center in China.

Authors:  Jun Zou; Jian-Feng Luo; Yan Shen; Jian-Fei Cai; Jian-Long Guan
Journal:  Arthritis Res Ther       Date:  2021-01-30       Impact factor: 5.156

10.  Associations of Mitochondrial Deoxyribonucleic Acid Polymorphisms With Behçet's Disease in the Korean Population.

Authors:  Mihye Kwon; Su-Jin Yoo; In Seol Yoo; Jinhyun Kim; Seong Wook Kang; In Ah Choi; Mi-Kyoung Lim; Chung-Il Joung
Journal:  Arch Rheumatol       Date:  2019-01-28       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.